Search results
Showing 1451 to 1500 of 1598 results for nice quality standards or clinical guidelines
Screening secondary care patients for atrial fibrillation: The SOS-AF service
implementation of all NICE guidance? No Does the example relate to a specific implementation of a specific piece of NICE...
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)
NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .
informed decisions when planning where to give birth. As per quality statement 1 of NICE QS105 on intrapartum care the...
Magseed for locating impalpable breast cancer lesions (MIB236)
NICE has developed a medtech innovation briefing (MIB) on Magseed for locating impalpable breast cancer lesions .
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease.
NICE has developed a medtech innovation briefing (MIB) on The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs .
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)
Evidence-based recommendations on ticagrelor (Brilique) for preventing atherothrombotic events after myocardial infarction in adults.
Secukinumab for treating moderate to severe hidradenitis suppurativa (TA935)
Evidence-based recommendations on secukinumab (Cosentyx) for active moderate to severe hidradenitis suppurativa (acne inversa) in adults.
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs (TA543)
Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs.
Upadacitinib for treating moderate rheumatoid arthritis (TA744)
Evidence-based recommendations on upadacitinib (Rinvoq) for treating moderate active rheumatoid arthritis in adults.
Sapropterin for treating hyperphenylalaninaemia in phenylketonuria (TA729)
Evidence-based recommendations on sapropterin for treating hyperphenylalaninaemia in phenylketonuria.
by NICE for common mental health disorders but can be difficult to access. Our project aims to evaluate the clinical and...
Evidence-based recommendations on naloxegol (Moventig) for treating opioid-induced constipation in adults.
Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease .
Evidence-based recommendations on abemaciclib (Verzenios) for treating locally advanced or metastatic, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer in adults who have not had endocrine-based therapy before.
mortality related to oesophageal cancer, and so we set out to develop regional guidelines for surveillance of Barrett's Oesophagus and...
NICE has developed a medtech innovation briefing (MIB) on cyanoacrylate glue for hernia mesh fixation .
improve evidence-based prescribing of high-cost biologic drugs in routine clinical practice, to reduce treatment delays and variations...
presence of detectable P waves. Practice described in this example relates to NICE Medical Technology Guidance (MTG) 24. Guidance
Ensuring compliance with NICE guidance significantly improves outcomes in Multiple Pregnancy
pregnancies. Our multiple pregnancy service has implemented 100% of the NICE Guidelines for multiple pregnancies. After...
describe the problem. National standards and relevant NICE guidelines were sourced and nationally recognised...
The successful implementation of a therapeutic class for treatment of Osteoarthritis
gym facilities to cater for the various types of services that we provide. NICE into Action 2019 Category, Chief Allied Health...
OASIS Group: improving quality of life in patients with lower limb Osteoarthritis
After reviewing the 2014 publication of NICE clinical guidance 177 (CG177) for Osteoarthritis: care and management in...
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant (TA640)
Evidence-based recommendations on treosulfan (Trecondi) with fludarabine for conditioning treatment before allogeneic haematopoietic stem cell transplant for malignant diseases in people for whom a reduced intensity regimen would be suitable.
work with patients to optimise prescribing through implementation of NICE NG28 guidelines for Type 2 diabetes. Guidance the
Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children (MIB163)
NICE has developed a medtech innovation briefing (MIB) on Serve-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children .
Entrectinib for treating NTRK fusion-positive solid tumours (TA644)
Evidence-based recommendations on entrectinib (Rozlytrek) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and children over 12 years.
LiMAx system for assessing the functional capacity of the liver (MIB168)
NICE has developed a medtech innovation briefing (MIB) on LiMAx system for assessing the functional capacity of the liver .
February 2018 NICE published updated guidance for Motor Neurone Disease (MND): assessment and
the team have been pivotal in launching and applying the principles of the NICE Alcohol withdrawal guidance through a Chlordiazepoxide...
Early value assessment is a new evidence-based approach designed to improve the care of people and effective use of NHS resources through quicker access to promising health technologies that address national unmet need. It champions stronger partnership working between regulatory, healthcare and research organisations to benefit people and better support innovators while ensuring value for money for the NHS
NICE has developed a medtech innovation briefing (MIB) on CentriMag for heart failure .
Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making
Research recommendations process and methods guide
Show all sections
Reducing the risk of C Difficile by reviewing the prescribing of high risk antibiotics
implementation of all NICE guidance? No Does the example relate to a specific implementation of a specific piece of NICE...
Innovative use of published NICE guidance to inform policy development and widen understanding
Quality Compliance Systems Published date: January 2018 Quality Compliance
patients, and that they can manufacture the medicine to the required quality. At NICE we do not license medicines - you can...
Larotrectinib for treating NTRK fusion-positive solid tumours (TA630)
Evidence-based recommendations on larotrectinib (Vitrakvi) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in adults and children.
TearLab osmolarity system for diagnosing dry eye disease (MIB47)
NICE has developed a medtech innovation briefing (MIB) on TearLab osmolarity system for diagnosing dry eye disease .
Breast reconstruction using lipomodelling after breast cancer treatment (IPG417)
Evidence-based recommendations on breast reconstruction using lipomodelling after breast cancer treatment. This involves taking fat from the abdomen or thighs and injecting it into the breast in the area of the deformity caused by surgery.
View recommendations for IPG417Show all sections
Sections for IPG417
bipolar), and to implement the recommendation for offering arts therapies in the NICE guidance for management of psychosis and...
Evidence-based recommendations on adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade), rituximab (MabThera) and abatacept (Orencia). These drugs are for adults with severe rheumatoid arthritis who have tried other disease-modifying antirheumatic drugs (DMARDs) but cannot tolerate them or they haven’t worked well enough.
Percutaneous electrical nerve stimulation for refractory neuropathic pain (IPG450)
Evidence-based recommendations on percutaneous electrical nerve stimulation for refractory neuropathic pain. This involves inserting electrode needles underneath the skin connected to a stimulator device.
View recommendations for IPG450Show all sections
Sections for IPG450
Summary of the evidence on oral glycopyrronium bromide for severe sialorrhoea (drooling) in children and young people with chronic neurological disorders
Wigan Borough CCG has employed a team of pharmacists and pharmacy technicians to work with GP practices, residential and nursing homes to carry out structured medication reviews for care homes
TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis (TA383)
Evidence-based recommendations on adalimumab (Humira), certolizumab pegol (Cimzia), etanercept (Enbrel), golimumab (Simponi) and infliximab (Remicade, Remsima, Inflectra). These drugs are for people with severe active ankylosing spondylitis or severe non-radiographic axial spondyloarthritis who have tried non-steroidal anti-inflammatory drugs (NSAIDs), but they have not worked.
March 2019 NICE recommend creative therapies for treatment of psychosis.( Psychosis and Schizophrenia
eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)
NICE has developed a medtech innovation briefing (MIB) on eazyplex SuperBug kits for detecting carbapenemase-producing organisms .